✦ LIBER ✦

PCV22: COST-EFFECTIVENESS OF ENOXAPARIN AS VENOUS THROMBOEMBOLISM PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS

✍ Scribed by G de Lissovoy; P Subedi; V Nadipelli

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of fondaparinux vs. e

✍ Jonas Lundkvist; David Bergqvist; Bengt Jönsson 📂 Article 📅 2003 🏛 Springer 🌐 French ⚖ 210 KB

Prophylaxis Against Venous Thromboemboli

✍ Dr. Carla M. Peterman; Dr. Daniel M. Kolansky; Dr. Sarah A. Spinler 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Venous thromboembolism prophylaxis in ac

✍ P. CHOPARD; J. DÖRFFLER-MELLY; U. HESS; W. A. WUILLEMIN; D. HAYOZ; A. GALLINO; E 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

Economic evaluation of enoxaparin for th

✍ Offord, Robin ;Lloyd, Adam C. ;Anderson, Pippa ;Bearne, Andy 📂 Article 📅 2004 🏛 Springer 🌐 Dutch ⚖ 123 KB

Venous thromboembolism prophylaxis of ac

✍ Batia Roth-Yelinek 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Venous thromboembolism prophylaxis of ac

✍ Moshe Vardi; Michal Haran 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 308 KB